Article

DNA methyltransferase inhibitors in myelodysplastic syndrome

2004-12-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 917dd242-a33c-5362-8277-f620dde7e607
DOI: 10.1016/s1521-6926(04)00076-3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DNA methyltransferase inhibitors in myelodysplastic syndromeDOI 10.1016/s1521-6926(04)00076-3Read

DNA Methyltransferase and Histone Deacetylase Inhibitors in the Treatment of Myelodysplastic SyndromesSemantic proximity Read

Role of DNA Methylation in the Pathogenesis and Treatment of Myelodysplastic SyndromesSemantic proximity Read

Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsSemantic proximity Read

Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selectionSemantic proximity Read

Up-regulation of DNA methyltransferases DNMT1, 3A, and 3B in myelodysplastic syndromeSemantic proximity Read

Current status of epigenetic treatment in myelodysplastic syndromesSemantic proximity Read

Inhibitors of DNA methylation in the treatment of hematological malignancies and MDSSemantic proximity Read

DNA Methylation–Targeted DrugsSemantic proximity Read

Epigenetics in myelodysplastic syndromesSemantic proximity Read

Epigenetic Changes in the Myelodysplastic SyndromeSemantic proximity Read

Established and emerging targeted therapies in the myelodysplastic syndromes.Semantic proximity Read

The biology and treatment of myelodysplastic syndromes.Semantic proximity Read